Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

Similar articles for PubMed (Select 8821398)

1.

Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.

Miura NN, Ohno N, Aketagawa J, Tamura H, Tanaka S, Yadomae T.

FEMS Immunol Med Microbiol. 1996 Jan;13(1):51-57.

PMID:
8821398
2.
3.

Inactivation of (1-->3)-beta-D-glucan in mice.

Miura T, Ohno N, Suda M, Miura NN, Shimada S, Yadomae T.

Biol Pharm Bull. 1995 Dec;18(12):1797-1801.

PMID:
8787813
4.

Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice.

Ohno N, Asada N, Adachi Y, Yadomae T.

Biol Pharm Bull. 1995 Jan;18(1):126-33.

PMID:
7735226
5.

Enhancement of hematopoietic response of mice by intraperitoneal administration of a beta-glucan, SSG, obtained from Sclerotinia sclerotiorum.

Hashimoto K, Suzuki I, Ohsawa M, Oikawa S, Yadomae T.

J Pharmacobiodyn. 1990 Aug;13(8):512-7.

PMID:
2079647
6.

Comparison of the blood clearance of triple- and single-helical schizophyllan in mice.

Miura NN, Ohno N, Adachi Y, Aketagawa J, Tamura H, Tanaka S, Yadomae T.

Biol Pharm Bull. 1995 Jan;18(1):185-9.

PMID:
7735240
7.

Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice.

Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T.

Biol Pharm Bull. 1996 Apr;19(4):608-12.

PMID:
8860968
8.

Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.

Suda M, Ohno N, Hashimoto T, Koizumi K, Adachi Y, Yadomae T.

FEMS Immunol Med Microbiol. 1996 Sep;15(2-3):93-100.

PMID:
8880133
9.

Relationship between the tissue distribution and antitumor activity of highly branched (1-->3)-beta-D-glucan, SSG.

Suda M, Ohno N, Adachi Y, Yadomae T.

Biol Pharm Bull. 1994 Jan;17(1):131-5.

PMID:
8148801
10.

Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.

Sakurai T, Suzuki I, Kinoshita A, Oikawa S, Masuda A, Ohsawa M, Yadomae T.

Chem Pharm Bull (Tokyo). 1991 Jan;39(1):214-7.

PMID:
2049804
11.

Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.

Sakurai T, Ohno N, Suzuki I, Yadomae T.

Immunopharmacology. 1995 Aug;30(2):157-66.

PMID:
8530257
12.
13.

Immunotoxicity of soluble beta-glucans induced by indomethacin treatment.

Yoshioka S, Ohno N, Miura T, Adachi Y, Yadomae T.

FEMS Immunol Med Microbiol. 1998 Jul;21(3):171-9.

14.
15.

Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.

Sakurai T, Kaise T, Yadomae T, Matsubara C.

Eur J Pharmacol. 1997 Sep 10;334(2-3):255-63.

PMID:
9369356
16.
17.

Changes in immune mediators in mouse lung produced by administration of soluble (1-->3)-beta-D-glucan.

Sakurai T, Ohno N, Yadomae T.

Biol Pharm Bull. 1994 May;17(5):617-22.

PMID:
7920419
20.

Immunomodulation by orally administered beta-glucan in mice.

Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T.

Int J Immunopharmacol. 1989;11(7):761-9.

PMID:
2599714
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk